📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives. (2024)

First Author: Lightner AL

Attributed to: Regulatory T cell therapy for IBD funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40259-024-00661-6

PubMed Identifier: 38914783

Publication URI: http://europepmc.org/abstract/MED/38914783

Type: Journal Article/Review

Volume: 38

Parent Publication: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Issue: 4

ISSN: 1173-8804